2022
Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown
Lu Y, Jones PW, Murugiah K, Caraballo C, Mahajan S, Massey D, Ahmed R, Bader E, Krumholz H. Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown. Journal Of Cardiac Failure 2022, 28: 1372-1374. PMID: 35690314, PMCID: PMC9187866, DOI: 10.1016/j.cardfail.2022.05.012.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillatorHeart failure patientsCRT-D devicesCardiac statusFailure patientsHeart failureCardioverter defibrillatorCardiac resynchronization therapy defibrillatorAcute cardiac conditionsMedical care deliveryInpatient careCardiac conditionsPhysiologic markersInpatient servicesPatientsCardiac healthCare deliveryMarked restrictionImplanted ICDsMinneapolis/Saint PaulSex subgroupsDefibrillatorCOVID-19Telemedicine servicesCOVID-19 lockdown
2009
Mortality and Readmission for Patients With Heart Failure Among U.S. News & World Report’s Top Heart Hospitals
Mulvey GK, Wang Y, Lin Z, Wang OJ, Chen J, Keenan PS, Drye EE, Rathore SS, Normand SL, Krumholz HM. Mortality and Readmission for Patients With Heart Failure Among U.S. News & World Report’s Top Heart Hospitals. Circulation Cardiovascular Quality And Outcomes 2009, 2: 558-565. PMID: 20031893, DOI: 10.1161/circoutcomes.108.826784.Peer-Reviewed Original ResearchConceptsRisk-standardized mortality ratesRisk-standardized readmission ratesReadmission ratesHeart failureMortality rateBest HospitalsAmerica's Best HospitalsMedical administrative dataReadmission analysisHeart HospitalHeart surgeryCardiac conditionsPatientsHospitalMortality analysisReadmissionAdministrative dataHierarchical regression modelsWorld ReportRegression modelsFailureReportSurgeryMortalityRate